Dabrafenib Mesylate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Dabrafenib Mesylate
U.S. EXCLUSIVITIES

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Dabrafenib Mesylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 1 USDMF, 1 EU WC, 2 NDC API, 11 Listed Suppliers, $ API Reference Price

12 API Suppliers
1 USDMF
1 EU WC
2 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

15 Intermediates Suppliers

15 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 5 FDA Orange Book, 5 Europe, 6 Australia, 2 South Africa

18 FDF Dossiers
5 FDA Orange Book
5 Europe
6 Australia
2 South Africa

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE

CAPSULE;ORAL - EQ 50MG BASE
CAPSULE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 6 Gangwal Healthcare, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem

1 SPI Pharma
3 DKSH
6 Gangwal Healthcare
1 ACG Worldwide
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
10 Corel Pharma Chem
2 DFE Pharma
6 Gangwal Chemicals
5 Ideal Cures Pvt Ltd
15 Kerry
3 Kima Chemical
6 Lonza Capsugel
8 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
1 Pluviaendo
2 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
9 Roquette
6 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
8 Sigachi Industries
2 The Dow Chemical Company
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 23 Fillers, Diluents & Binders, 20 Controlled & Modified Release, 14 Direct Compression, 12 Thickeners and Stabilizers, 11 Lubricants & Glidants, 8 Co-Processed Excipients, 7 Film Formers & Plasticizers, 7 Granulation, 6 Disintegrants & Superdisintegrants, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Taste Masking, 4 API Stability Enhancers, 4 Coloring Agents, 4 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 Rheology Modifiers, 1 Solubilizers

43 Coating Systems & Additives
23 Fillers, Diluents & Binders
20 Controlled & Modified Release
14 Direct Compression
12 Thickeners and Stabilizers
11 Lubricants & Glidants
8 Co-Processed Excipients
7 Film Formers & Plasticizers
7 Granulation
6 Disintegrants & Superdisintegrants
5 Empty Capsules
4 Vegetarian Capsules
4 Taste Masking
4 API Stability Enhancers
4 Coloring Agents
4 Emulsifying Agents
3 Chewable & Orodispersible Aids
2 Rheology Modifiers
1 Solubilizers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 44 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
44 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 Finished Drug Prices, 10 Annual Reports

5 Finished Drug Prices
10 Annual Reports

MARKET PLACE

3 APIs, 1 FDF Dossiers

3 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

68 US Patents, 28 US Exclusivities, 2 Health Canada Patents

68 US Patents
28 US Exclusivities
2 Health Canada Patents

$ API Ref.Price (USD/KG) : 78,477 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

28 All

01 28NOVARTIS

filter Product Reset all filters

28 All

01 28DABRAFENIB MESYLATE

filter Exclusivity Expiration Date Reset all filters

28 All

01 22024-06-22

02 22024-12-22

03 22025-04-30

04 22025-05-04

05 22025-06-22

06 22025-10-30

07 22025-11-04

08 22025-12-22

09 32026-03-16

10 32026-09-16

11 32030-03-16

12 32030-09-16

filter Exclusivity Code Reset all filters

28 All

01 2I-894

02 2I-908

03 1NP

04 2ODE-147

05 2ODE-182

06 2ODE-183

07 3ODE-428

08 14PED

Product Main Page

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-908

Exclusivity Expiration Date

2026-03-16

Application Number

202806

Product Number

1

Exclusivity Details

01

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : I-908

Exclusivity Expiration Date : 2026-03-16

Application Number : 202806

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-428

Exclusivity Expiration Date

2030-03-16

Application Number

202806

Product Number

1

Exclusivity Details

02

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : ODE-428

Exclusivity Expiration Date : 2030-03-16

Application Number : 202806

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-147

Exclusivity Expiration Date

2024-06-22

Application Number

202806

Product Number

1

Exclusivity Details

03

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : ODE-147

Exclusivity Expiration Date : 2024-06-22

Application Number : 202806

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-183

Exclusivity Expiration Date

2025-05-04

Application Number

202806

Product Number

1

Exclusivity Details

04

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : ODE-183

Exclusivity Expiration Date : 2025-05-04

Application Number : 202806

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-428

Exclusivity Expiration Date

2030-03-16

Application Number

202806

Product Number

2

Exclusivity Details

05

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : ODE-428

Exclusivity Expiration Date : 2030-03-16

Application Number : 202806

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-182

Exclusivity Expiration Date

2025-04-30

Application Number

202806

Product Number

1

Exclusivity Details

06

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : ODE-182

Exclusivity Expiration Date : 2025-04-30

Application Number : 202806

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-147

Exclusivity Expiration Date

2024-06-22

Application Number

202806

Product Number

2

Exclusivity Details

07

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : ODE-147

Exclusivity Expiration Date : 2024-06-22

Application Number : 202806

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-183

Exclusivity Expiration Date

2025-05-04

Application Number

202806

Product Number

2

Exclusivity Details

08

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : ODE-183

Exclusivity Expiration Date : 2025-05-04

Application Number : 202806

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-182

Exclusivity Expiration Date

2025-04-30

Application Number

202806

Product Number

2

Exclusivity Details

09

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : ODE-182

Exclusivity Expiration Date : 2025-04-30

Application Number : 202806

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

NOVARTIS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DABRAFENIB MESYLATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-894

Exclusivity Expiration Date

2025-06-22

Application Number

202806

Product Number

1

Exclusivity Details

10

NOVARTIS

DABRAFENIB MESYLATE

2024 ACI Convention

Not Confirmed

NOVARTIS

Switzerland

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DABRAFENIB MESYLATE

Exclusivity Code : I-894

Exclusivity Expiration Date : 2025-06-22

Application Number : 202806

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?